Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.
Stopped early · Not applicable
Conditions studied: Upper Gastrointestinal Bleeding
In brief
This is a study comparing the effect of erythromycin or metoclopramide, 2 prokinetic drugs (Drugs which are known to speed up the emptying of the stomach or in other words to move the blood out of the stomach faster) given before endoscopy to patients with upper Gastrointestinal bleeding compared to patients who will not receive either of these medications before their endoscopy.
Key facts
- Study ID
- NCT02017379
- Run by
- Texas Tech University Health Sciences Center, El Paso
- People needed
- 4
- Starts
- 2014-06-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2021-03-04
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients (18-80)
- who are admitted to the ICU for hematemesis, or coffee ground emesis
You may not qualify if…
- Patients younger than 18 yrs old or older than 80 yrs
- Patients who refuse to consent to be in our study
- Pregnant patients
- Prior use of prokinetics in the last 48 hours
- History of cardiac arrhythmia
- Allergy to erythromycin or metoclopromide
- Patients with QT prolongation (query 7)
Where it is running
- Texas Tech University Health Science Center — El Paso, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.